Home/Filings/4/0001181431-12-026457
4//SEC Filing

BERGERON JOHN P 4

Accession 0001181431-12-026457

CIK 0000887568other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 6:16 PM ET

Size

21.8 KB

Accession

0001181431-12-026457

Insider Transaction Report

Form 4
Period: 2012-04-26
BERGERON JOHN P
VP & Corporate Treasurer
Transactions
  • Exercise/Conversion

    Stock Options

    2012-04-261,6280 total
    Exercise: $25.09From: 2009-04-22Exp: 2018-04-22Common Stock (1,628 underlying)
  • Exercise/Conversion

    Common Stock

    2012-04-26$25.09/sh+1,628$40,8472,828 total
  • Exercise/Conversion

    Common Stock

    2012-04-26$14.91/sh+1,800$26,8384,628 total
  • Exercise/Conversion

    Common Stock

    2012-04-26$27.79/sh+10,000$277,90014,628 total
  • Exercise/Conversion

    Stock Options

    2012-04-261,2000 total
    Exercise: $28.30From: 2008-04-24Exp: 2017-04-24Common Stock (1,200 underlying)
  • Exercise/Conversion

    Stock Options

    2012-04-261,8000 total
    Exercise: $14.91From: 2010-04-21Exp: 2019-04-21Common Stock (1,800 underlying)
  • Tax Payment

    Common Stock

    2012-04-262730 total
  • Disposition to Issuer

    Common Stock

    2012-04-26$93.00/sh14,628$1,360,4040 total
  • Exercise/Conversion

    Stock Options

    2012-04-2610,0000 total
    Exercise: $27.79From: 2011-04-27Exp: 2020-04-27Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-04-26$28.30/sh+1,200$33,9601,200 total
  • Disposition to Issuer

    Common Stock

    2012-04-26$93.00/sh527$49,0110 total
Footnotes (3)
  • [F1]These restricted stock awards vested in full and were cancelled immediately prior to the effective time of the merger (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated March 12, 2012, by and amoung ZOLL Medical Corporation, Asahi Kasei Corporation, Asahi Kasei Holdings US, Inc. and Asclepius Subsidiary Corporation (the "Merger Agreement") in exchange for an aggregate cash payment equal to the number of shares of ZOLL Medical Corporation's common stock underlying such restricted stock awards multiplied by the per share purchase price of $93.00.
  • [F2]Disposed of at the effective time of the Merger pursuant to the terms of the Merger Agreement.
  • [F3]Represents options under ZOLL Medical Corporation's Amended and Restated 2001 Stock Incentive Plan that were either fully exercisable or accelerated in full and exercised pursuant to the terms of the Merger Agreement.

Issuer

ZOLL MEDICAL CORP

CIK 0000887568

Entity typeother

Related Parties

1
  • filerCIK 0001243330

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 6:16 PM ET
Size
21.8 KB